The T cell immune response against SARS-CoV-2
P Moss - Nature immunology, 2022 - nature.com
The adaptive immune response is a major determinant of the clinical outcome after SARS-
CoV-2 infection and underpins vaccine efficacy. T cell responses develop early and …
CoV-2 infection and underpins vaccine efficacy. T cell responses develop early and …
[HTML][HTML] SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
S Pilz, V Theiler-Schwetz, C Trummer, R Krause… - Environmental …, 2022 - Elsevier
Seroprevalence surveys suggest that more than a third and possibly more than half of the
global population has been infected with SARS-CoV-2 by early 2022. As large numbers of …
global population has been infected with SARS-CoV-2 by early 2022. As large numbers of …
Association between mRNA vaccination and COVID-19 hospitalization and disease severity
Importance A comprehensive understanding of the benefits of COVID-19 vaccination
requires consideration of disease attenuation, determined as whether people who develop …
requires consideration of disease attenuation, determined as whether people who develop …
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
INTRODUCTION Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA
vaccines are highly effective at preventing infection and especially severe disease …
vaccines are highly effective at preventing infection and especially severe disease …
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
Predictive models of immune protection from COVID-19 are urgently needed to identify
correlates of protection to assist in the future deployment of vaccines. To address this, we …
correlates of protection to assist in the future deployment of vaccines. To address this, we …
Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?
The rapid development of multiple vaccines providing strong protection from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a major achievement …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a major achievement …
[HTML][HTML] Sustained effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 associated hospitalizations among adults—United States, March–July …
MW Tenforde - MMWR. Morbidity and mortality weekly report, 2021 - cdc.gov
Among 1,129 patients who received 2 doses of a mRNA vaccine, no decline in vaccine
effectiveness against COVID-19 hospitalization was observed over 24 weeks. Vaccine …
effectiveness against COVID-19 hospitalization was observed over 24 weeks. Vaccine …
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA. 1 and BA. 2 by convalescent and vaccine serum and monoclonal antibodies
Summary Background In recent months, Omicron variants of SARS-CoV-2 have become
dominant in many regions of the world, and case numbers with Omicron subvariants BA. 1 …
dominant in many regions of the world, and case numbers with Omicron subvariants BA. 1 …
Estimated US infection-and vaccine-induced SARS-CoV-2 seroprevalence based on blood donations, July 2020-May 2021
Importance People who have been infected with or vaccinated against SARS-CoV-2 have
reduced risk of subsequent infection, but the proportion of people in the US with SARS-CoV …
reduced risk of subsequent infection, but the proportion of people in the US with SARS-CoV …
SARS-CoV-2-specific T cells in infection and vaccination
During viral infections, antibodies and T cells act together to prevent pathogen spread and
remove virus-infected cells. Virus-specific adaptive immunity can, however, also trigger …
remove virus-infected cells. Virus-specific adaptive immunity can, however, also trigger …